Categories Earnings, Technology

Despite headwinds, revenues grow 10% for Marvell Technology in Q1

Marvell Technology Group (NASDAQ: MRVL) on Thursday reported better-than-expected results, sending the stock up 2% during after-market hours.  

The chipmaker reported a 9.6% growth in revenues to $662  million in the first quarter of 2019. Adjusted EPS, meanwhile, halved year-over-year to 16 cents per share. Analysts were expecting the chipmaker to post Q1 earnings of 14 cents per share on revenues of $650.21 million.

Marvell stock has gained 34.5% so far this year.

Outlook

For the second quarter, the company projects revenue to be about $650 million, while adjusted earnings are expected to come in the range of $0.13 to $0.17 per share.

Marvell CEO Matt Murphy said, “With the production ramp of our first 5G products later this year, and a growing pipeline of new wireless infrastructure design wins, Marvell is well positioned to becoming a leading silicon supplier to this market.”

READ: THIS TIME ELON MUSK GETS AN AWARD FOR HIS TWEETS

Earlier this week, rival NXP Semiconductors (NASDAQ: NXPI) had announced its plan to acquire Marvell’s Wi-Fi Connectivity business, in a deal that is expected to enhance Marvell’s margins. The transaction is expected to close by March 2020.

Marvell and its peers have been facing the brunt of weak macros, reduction in spending from their clients and a shortage of CPUs, which has been reflected in their earnings. However, the company is seeing strong demand for its networking products from 4G and 5G deployments.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top